Cornerstone Therapeutics Company
Cornerstone Therapeutics Inc. (NASDAQ: CRTX) is a specialty pharmaceutical company focused on developing, acquiring, and commercialising products for the respiratory, hospital and related specialty markets. Key elements of the Company's strategy are to focus on identifying therapeutic niches within respiratory, hospital and related specialty markets to leverage existing business and create new opportunities.
Founded Date:
01.01.2000
Last Funding Type:
EKR Therapeutics acquired by Cornerstone Therapeutics
Headquarters:
Cary, USA
Investors Number:
1
Technology:
Specific disorder-related
Employee Number:
51-100
Industry:
Treatment range
Estimated Revenue:
$10-50 Mn
Last Funding Date:
15.05.2012
Funding Status:
Acquired/Merged
Total Funding:
$0